{
}
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
The global Keratoconus Treatment market, valued at US$ 0.5 billion in 2022, is projected to grow to US$ 0.6 billion by 2031, with a CAGR of 3.9% from 2024 to 2031. Key players include Sandoz International GmbH, HOYA, and Menicon Co., Ltd., focusing on various treatment options like corrective lenses and corneal surgeries. Recent developments highlight Menicon's launch of the ROSE K hard contact lens in China, tailored for keratoconus patients.
UBS has maintained a "Neutral" rating for Carl Zeiss Meditec, setting a price target of 65 euros, following disappointing fourth-quarter results. The company's operating profit forecast for 2025 is over 10% below market expectations, with management citing a weak economy and consumption pressures in China, which may negatively impact investor sentiment.
Carl Zeiss Meditec AG, a German technology and medical devices firm, specializes in solutions for diagnosing and treating ophthalmic diseases, as well as providing visualization tools for microsurgery. The company operates in two main sectors: ophthalmic devices, which includes intraocular lenses and medical lasers, and microsurgery, covering neurosurgery and otolaryngology. With production sites across Europe, the U.S., and Asia, it continues to innovate in the medical technology field.
UBS has maintained a "Neutral" rating for Carl Zeiss Meditec, setting a target price of 65 euros. Analyst Graham Doyle expresses skepticism about the medical technology sector, noting that his sales and earnings forecasts for 2025 fall below consensus estimates for 10 of the 17 stocks he covers.
UBS has maintained a 'Neutral' rating for Carl Zeiss Meditec, setting a target price of 65 euros. Analyst Graham Doyle expresses skepticism about the medical technology sector, noting that his sales and earnings forecasts for 2025 fall below consensus for 10 of the 17 stocks he covers.
UBS has maintained a 'Neutral' rating for Carl Zeiss Meditec, setting a price target of 65 euros. Analyst Graham Doyle expressed skepticism about the medical technology sector, noting that his sales and earnings forecasts for 2025 are below consensus for 10 of the 17 stocks he covers. As of the latest trading, Carl Zeiss Meditec shares are priced at 57.85 euros, reflecting a slight increase of 0.26%.
The German ophthalmic devices market is projected to grow at a CAGR of 5.34% from 2023 to 2033, driven by the rising prevalence of eye disorders and an aging population. Key segments include cataract treatments, which are expected to dominate due to high demand for advanced surgical solutions. Recent developments include Carl Zeiss Meditec AG's acquisition of D.O.R.C., enhancing its ophthalmic portfolio.
The French ophthalmic devices market is projected to grow at a CAGR of 4.1% from 2023 to 2033, driven by rising ophthalmic diseases and technological advancements. Key segments include cataract treatments and eye hospitals, with increased mergers and acquisitions expected to enhance facility demand. Major players include Hoya, Alcon, and Bausch Healthcare.
UBS has reduced its price target for Carl Zeiss Meditec from 71 to 65 euros while maintaining a "Neutral" rating. Analyst Graham Doyle suggests that the current risk-reward profile does not warrant immediate investment in the medical technology company.
UBS has reduced its price target for Carl Zeiss Meditec from 71 to 65 euros while maintaining a "Neutral" rating. Analyst Graham Doyle indicates that the investment landscape remains unattractive due to an unfavorable balance of opportunities and risks, following a weak year for the company.
Carl Zeiss Meditec AG
Companies
Bausch Health Companies Inc.
Menicon Co., Ltd.
Seed Co. Ltd.
Johnson & Johnson Services Inc.
The Cooper Companies, Inc.
Novartis AG
Hoya Corp
Carl Zeiss Meditec AG
FRA
ARG
ARE
CAN
SAU
USA
RUS
IND
AUS
GBR
BHR
ITA
OMN
KWT
BRA
QAT
COL
DEU
CHN
MEX
ISR
JPN
Show more
14:48 09.01.2025
18:57 13.12.2024
10:38 11.12.2024
11:31 26.11.2024
10:31 26.11.2024
10:31 26.11.2024
Euro
Carl Zeiss Meditec AG
Topcon Corporation
Metall Zug Ltd.
Alcon Inc.
Bausch & Lomb Corp
EssilorLuxottica Société anonyme
DEU
FRA
Show more
09:40 19.11.2024
Hoya Company
Bausch Healthcare Inc.
HAAG-Streit Group
Ziemer Ophthalmic Systems AG
EssilorLuxottica Société anonyme
Topcon Company
Carl Zeiss Meditec AG
Johnson et Johnson
Nidek Co. Ltd
Alcon Inc.
FRA
Show more
09:24 19.11.2024
11:11 29.10.2024
08:13 29.10.2024
Trending
Subcategory:
Cryptocurrency Markets
Stock Market Updates
Cryptocurrency Trends
Cryptocurrency & Blockchain Regulations
Central Bank Actions
Market Sentiment Analysis
Banking & Investment Regulations
Employment Reports
Banking Regulations
Corporate Responsibility & ESG
Anti-Money Laundering (AML) Regulations
Inflation Rates & CPI Data
Blockchain Technology Adoption
Hedge Funds & Private Equity
Cryptocurrency Regulations
Tokenomics and Crypto Economics
Decentralized Finance (DeFi) Innovations
Mergers & Acquisitions
Emerging Startups
Cryptocurrency Developments
Countries:
Companies:
Currencies:
People:
Coinbase Global, Inc.
Apple Inc.
NVIDIA Corporation
Solana USD
Ethereum USD
Tesla, Inc.
Chainlink USD
Bitwise Bitcoin ETF
Fidelity Contrafund
UBS Group AG
BlackRock, Inc.
MicroStrategy Inc
Delta Air Lines, Inc.
Kraken Energy Corp.
Ripple USD USD
Ripples USD
Microsoft Corporation
Standard Chartered PLC
Novartis AG
Bank of America Corporation
United States Dollar
Euro
Swiss Franc
British Pound Sterling
Japanese Yen
Indian Rupee
Swedish Krona
Chinese Yuan
Canadian Dollar
Singapore Dollar
South Korean Won
New Taiwan Dollar
Thai Baht
Philippine Peso
Russian Ruble
Vietnamese Đồng
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.